Palvella Therapeutics, Inc. Available-for-sale Securities, Gross Realized Gain (Loss)
Palvella Therapeutics, Inc. (PVLA) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2018-08-09
- Palvella Therapeutics, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-06-30 was $0.00.
- Palvella Therapeutics, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-03-31 was $0.00.
- Palvella Therapeutics, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2017 was $0.00.
- Palvella Therapeutics, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2016 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-15 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | ||
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |